final program

 

Click here to download Final Program as a pdf.


Saturday,
July 27, 2013
Sunday,
July 28, 2013
Monday,
July 29, 2013
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

 

Sunday, July 28, 2013

08:30-10:30   HALL A
 

PL07    Plenary Session:
PATHOGENESIS, DIAGNOSIS AND TREATMENT OF AORTIC ANEURYSMS AND PERIPHERAL ARTERY DISEASE
 

Chairs:
J.A. Elefteriades, New Haven, CT, USA
S.D. Gertz, Jerusalem, Israel

 
08:30 IGE ACTIVITIES ON CD4+ T CELLS ARE EQUALLY IMPORTANT TO THOSE ON MAST CELLS IN EXPERIMENTAL ABDOMINAL AORTIC ANEURYSMS (Invited Lecture)
J. Wang, J.S. Lindholt, P. Libby, G.P. Shi
Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
179
08:45 LESSONS FROM ANIMAL MODELS OF ARTERIAL ANEURYSM (Invited Lecture)
S.D. Gertz, L. Gavish
The Hebrew University - Hadassah Medical School, Jerusalem, Israel
 
180
09:00 PRACTICAL GENETICS OF THORACIC AORTIC ANEURYSM (Invited Lecture)
J.A. Elefteriades, Aortic Institute at Yale-New Haven, New Haven, CT, USA
181
09:15 UPDATE ON AHA GUIDELINES FOR MANAGEMENT OF THORACIC AORTIC DISEASE (Invited Lecture)
A.T. Yetman, University of Utah, Salt Lake City, UT, USA
182
09:30 POLYVASCULAR DISEASE: DIAGNOSIS AND TREATMENT (Invited Lecture)
T. Tomaru, J. Suzuki, T. Matsubara, E. Matsubara, Y. Minami
Toho University Sakura Hospital, Japan
183
09:45 CORRELATION BETWEEN AORTIC ROOT DILATION AND DIASTOLIC DYSFUNCTION
P. Rodriguez-Lozano, W.I. Khalife, M. Morsy, S. Mutnuri, A. Khan
UTMB, Galveston, TX, USA
185
10:00 THE DA VINCI ROBOT AND NEW ERA OF VASCULAR SURGERY
P. Stadler, L. Dvoracek, P. Vitasek, P. Matouš
Na Homolce Hospital, Praha, Czech Republic
186
10:15 ENDOVENOUS ABLATION THERAPY FOR TREATMENT OF VENOUS INSUFFICIENCY: COMPARATIVE STUDY EVALUATING EFFICACY BETWEEN LASWER AND RADIOFREQUENY IN SYMPTOMATIC VENOUS INSUFFICIENCY
L.M. Slusher, Niyanthesh A. Reddy, Navya A. Reddy, D.L. Slusher, Nagendar A. Reddy
Lorven Heart & Vascular Institute, Ocala, FL, USA
189
10:30 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 28, 2013
08:30-11:00   HALL B

 

PL08   Plenary Session:
VASCULAR BIOLOGY, IMMUNE MEDIATED SURVIVAL AND OXIDATIVE STRESS

Chairs:
T. Malinski, Athens, OH, USA
K. Maiese, Jersey City, NJ, USA

 

08:30 STATIN EFFECTS BEYOND LIPID LOWERING: ATORVASTATIN INHIBITION OF MYOCARDIN EXPRESSION IN VASCULAR SMOOTH MUSCLE (Invited Lecture)
X.L. Zheng, University of Calgary, Calgary, AB, Canada
188
08:45 CROSS-TALK BETWEEN NADPH OXIDASE AND MITOCHONDRIA FOR ROS-DEPENDENT VEGF SIGNALING AND ANGIOGENESIS (Invited Lecture)
M. Ushio-Fukai, University of Illinois at Chicago, Chicago, IL, USA
 
189
09:00 mTOR SIGNALING IN VASCULAR AND IMMUNE MEDIATED DISEASE (Invited Lecture)
K. Maiese, Mitsubishi Tanabe Pharma, Jersey City, NJ, USA
 
190
09:15 CORONARY VASOMOTOR REGULATION BY ENDOTHELIN-1 AND OXIDATIVE STRESS (Invited Lecture)
L. Kuo, G. Lu, T.W. Hein, Texas A&M Health Science Center, Temple, TX, USA
191
09:30 THE ROLE OF NITRIC OXIDE/PEROXYNITRITE IMBALANCE IN THE ISCHEMIC HEART (Invited Lecture)
H. Wang, T. Malinski, Ohio University, Athens, OH, USA
193
09:45 DIHYDROFOLATE REDUCTASE IN CARDIOVASCULAR PATHOPHYSIOLOGY (Invited Lecture)
H. Cai, UCLA David Geffen School of Medicine Los Angeles, CA, USA
194
10:00

THIOREDOXIN-1 GENE THERAPY FOR CARDIOVASCULAR DISEASE (Invited Lecture)
N. Maulik, University of Connecticut School of Medicine, Farmington, CT, USA

303
10:15 HYPERCHOLESTEROLEMIA-INDUCED OXIDATIVE STRESS 195 IN THE HEART (Invited Lecture)
K. Prasad, University of Saskatchewan, Saskatoon, SK, Canada
195
10:30 IL-10 AND INNATE SIGNALING IN CARDIOMYOCYTE PROTECTION (Invited Lecture)
A. Bagchi, A. Sharma, G. Akolkar, P.K. Singal
St. Boniface General Hospital Research Centre, Winnipeg, MN, Canada
192
10:45 CD137 DEFICIENCY REDUCES THE DEVELOPMENT AND PLAQUE INSTABILITY OF ATHEROSCLEROSIS
G.T. Oh, I.H. Jung, J. Jin, D.Y. Kim
Ewha Womans University, Seoul, Korea
196
11:00 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 28, 2013
08:30 - 11:00   HALL C
  S26   Session:  
NEW DIAGNOSTIC METHODS AND IMAGING TECHNIQUES

Chairs:
T. Akasaka, Wakayama, Japan
T. Tomaru, Chiba, Japan
 
08:30 SAFETY OF ECHOCARDIOGRAPHIC CONTRAST IN HOSPITALIZED PATIENTS WITH PULMONARY HYPERTENSION: A MULTICENTER STUDY
V. Suma, O. Wever-Pinzon, A. Ahuja, J. Romero, N. Sareen, S.A. Henry, M.D. Zunino, F.F. Chaudhry, R.S. Suryadevara, F.A. Chaudhry
North Shore University Hospital, Hofstra NS-LIJ School of Medicine, Manhasset, NY, USA
197
08:45 MDCT QUANTIFICATION OF EXTRACELLULAR VOLUMES IN ACUTE AND SCARRED MYOCARDIAL INJURIES
L. Do, M.W. Wilson, M. Suhail, S.W. Hetts, M. Saeed
University of California San Francisco, San Francisco, CA, USA
198
09:00 LONG-TERM FOLLOW-UP OF CORONARY COMPUTED TOMOGRAPHY IN PATIENTS WITH CHEST PAIN AT INTERMEDIATE RISK
F.B. Sozzi, F. Civaia, P. Rossi, J.F. Robillon, S. Rusek, F. Bertier,
F. Bourlon, L. Iacuzio, G. Drayfus, V. Dor
Fondazione IRCCS Cà Granda, Cardiology, Milan, Italy
199
09:15 WHO IS YOUNG AT HEART AND WHEN? DATA FROM THE MIND YOUR HEART STUDY
S. Pursnani, K. Singh, S. Lahsaei, B. Ristow, R.E. Shaw, B.E. Cohen, N. Schiller, California Pacific Medical Center; San Francisco, CA, USA
200
09:30 OPTICAL COHERENCE TOMOGRAPHY FINDINGS OF LESION WITH VERY LATE RESTENOSIS AFTER BARE METAL STENT IMPLANTATION
M. Habara, M. Terashima, K. Nasu, T. Teramoto, M. Kimura, Y. Kinoshita, E. Tsuchikane, Y. Asakura, T. Matsubara, T. Suzuki
Toyohashi Heart Center, Toyohashi, Aichi, Japan
201
09:45 CORONARY CHRONIC TOTAL OCCLUSIONS; EVALUATION AND PREDICTION OF PERCUTANEOUS INTERVENTION OUTCOME BY COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY AS COMPARED TO CONVENTIONAL CORONARY ANGIOGRAPHY
S. Elkaffas
, S. Sumitsuji, A. Hassan-Mostafa, K. Said, H. Kandil, S. Nanto
Cairo University, Department of Cardiology, Cairo, Egypt
202
10:00 UNVEILING RESTRICTIVE CARDIOMYOPATHIES WITH CARDIAC MAGNETIC RESONANCE
N.R. Aggarwal, Mayo Clinic, Rochester, MN, USA
203
10:15 LOW RISK CHEST PAIN PATIENTS MIGHT NOT BENEFIT FROM IN PATIENT STRESS TESTING
Y. Nawaz, B. Ayub, D. Schneider, R.A Watson
Lehigh Valley Hospital, Allentown, PA, USA
204
10:30 NON-INVASIVE ASSESSMENT OF THE LEFT VENTRICULAR END-DIASTOLIC PRESSURE USING PORTABLE ULTRASOUND MEASUREMENTS OF THE RIGHT INTERNAL JUGULAR VEIN
G.T. Jao, R.W. Savage, J. Li, K. Buchanan, D.C. Sane Carilion Clinic-Virginia Tech School of Medicine, Roanoke, VA, USA
205
10:45 THE INFLUENCE OF EARLY TRAINING IN TRANS-RADIAL VERSUS TRANS-FEMORAL APPROACH DURING SELECTIVE CORONARY ANGIOGRAPHY
S. Sudhakar, M. Bheemarasetti, W. Khalife, A. al Emam, S. Cherry, A. Almomani, A. Sharife, S. Onguti, S. Gilani
University of Texas Medical Branch, Galveston, Texas, USA
206
11:00 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 28, 2013
08:30 - 11:00   HALL D
  S27   Session:  
ACUTE CORONARY SYNDROMES: DETECTION, PREVENTION AND TREATMENT

Chairs:
M.R. Movahed, Tuscon, AZ, USA
B.F. Uretsky, Little Rock, AR, USA
 
08:30 CORONARY COLLATERALS ARE NOT CARDIOPROTECTIVE IN MULTIETHNIC STEMI PATIENTS AFTER REVASCULARIZATION
A. Avezbadalov, A. Jaiswal, E.N. Moustakakis, C.H. Park, A.J. Buda
New York Hospital Queens, Weill Cornell Medical College, New York, NY, USA
207
08:45 MICROVASCULAR OBSTRUCTION LIMITS MYOCARDIAL INFARCT RESORPTION
H. Bajwa, M.W. Wilson, L. Do, S.W. Hetts, M. Saeed
University of California San Francisco, CA, USA
208
09:00 ACUTE MYOCARDIAL INFARCTION AND MULTIVESSEL DISEASE: DIFFERENT PERCUTANEOUS REVASCULARIZATION STRATEGIES IN REAL WORLD
A. Manari, E. Varani, P. Guastaroba, M. Menozzi, M. Valgimigli, L. Vignali, P. Magnavacchi, A. Marzocchi, G. Casella
S. Maria Nuova Hospital, Reggio Emilia, Italy
209
09:15 INFLAMMATION/LIPID SCORE MAY OUTPERFORM TIMI SCORE FOR PREDICTION OF PCI-TREATED STEMI OUTCOMES
J.D. Kasprzak
, K. Kolodziej, J.Z. Peruga, Z. Bednarkiewicz, M. Krzeminska-Pakula, T. Rechciski
Medical University of Lodz, Lodz, Poland
210
09:30 OUTCOME OF PATIENTS WITH ACUTE CORONARY SYNDROME REQUIRING INTENSIVE CARE UNIT ADMISSION
A Jain, R. Giri, H. Luckraz, New Cross Hospital, Wolverhampton, UK
211
09:45 IS STEMI AS COMMON AS WE THINK IN SYMPTOMATIC PATIENTS 212 WITH LEFT BUNDLE BRANCH BLOCK?
F.A Alkindi, A.M. Arabi, A.A. Patel, A. Gehani, R. Singh, J. Alsuwaidi, H. Albinali
Hamad Medical Corporation, Doha, Qatar
 
212
10:00 QT DISPERSION AND T WAVE PEAK TO END TIME SIGNIFICANTLY CHANGE AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE ST ELEVATION
V. Eslami, M. Safi, M. Taherkhani, A. Adibi, M.R. Movahed
University of Arizona, USA
 
213
10:15 MICROEMBOLI EEFECTS ON LEFT VENTRICULAR FUNCTION, NECROSIS BIOMARKERS AND HISTOPATHOLOGY IN PRE-EXISTING AMI
L. Do, M.W. Wilson, J. Murayama, S. Nahi, S. Tse, B. Thorne, M. Suhail, S. Hetts, M. Saeed
University of California San Francisco, San Francisco, CA, USA
 
214
10:30 ACUTE MYOCARDIAL INFARCTION IN HOSPITALIZED PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
N. Balasubramaniyam, D.S. Kolte, C. Palaniswamy, K. Yalamanchili, W.S. Aronow, J.A. McClung, S. Khera, M. Mujib, S. Sule, SJ Peterson
Internal Medicine, New York Medical College, Valhalla, NY, USA
216
10:45 ANALYSIS OF CURRENT TREATMENT AND OUTCOMES FOR ACUTE MYOCARDIAL INFARCTION IN ETHIOPIA
S. Zaeh, A. Giday, C. Smitson, E. Weldeyes, J. O’Mara
Yale University, New Haven, CT, USA
 
217
11:00 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 28, 2013
11:15-14:00   HALL A
 

PL09    Plenary Session:
VALVULAR HEART DISEASE: MECHANISMS, IMAGING AND TREATMENT OPTIONS
Joint Session with the Heart Valve Society of America
 

Chairs:
J.S. Borer, New York, NY, USA
N.M. Rajamannan, Chicago, IL, USA

 
11:15 ANTICOAGULATION AND HEART VALVE DISEASE: IS IT TIME TO RECONSIDER WHO AND HOW? (Invited Lecture)
J.S. Borer, State University of New York Downstate Medical Center, New York, NY, USA
218
11:30 NEW INSIGHT INTO TREATMENT OF AORTIC STENOSIS: LIGHT AT THE END OF THE TUNNEL (Invited Lecture)
D.D. Heistad, R.M. Weiss, University of Iowa College of Medicine, Iowa City, IA, USA
219
11:45 TRANSAPICAL TRANSCATHETER AORTIC VALVE REPLACEMENT IN THE PRESENCE OF A MITRAL PROSTHESIS (Invited Lecture)
J. Ye, University of British Columbia, Vancouver, BC, Canada
220
12:00 OXIDATIVE-MECHANICAL SIGNALING ACTIVATES Wnt3a-Lrp5 MEDIATED AORTIC VALVE OSTEOGENESIS IN BICUSPID AORTIC VALVE DISEASE (Invited Lecture)
N.M. Rajamannan, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
221
12:15 EVOLVING TREATMENT STRATEGIES FOR TRICUSPID VALVE DISEASE (Invited Lecture)
H.K. Reddy, R.C. Komatireddy, R.K. Sharma, D.J. Voelker
University of Arkansas for Medical Sciences, Little Rock, AR, USA
222
12:30 TAVI - WAVE OF THE FUTURE OR TIME FOR A DEEP BREATH? (Invited Lecture)
H.L. Lazar, Boston Medical Center, Boston, MA, USA
223
12:45 TRANSESOPHAGEAL ECHOCARDIOGRAPHY FOR TRANSCATHETER AORTIC VALVE REPLACEMENT (Invited Lecture)
S. Lerakis, P. Block, V. Thourani, R. Guyton, V. Babaliaros Emory University Hospital, Atlanta, GA, USA
224
13:00 ASYMPTOMATIC SEVERE AORTIC STENOSIS: OPERATE OR WAIT? (Invited Lecture)
H.P. Chaliki, Mayo Clinic, Scottsdale, AZ, USA
225
13:15 EARLY SURGERY IN MITRAL REGURGITATION: IS IT A NEW TREND? (Invited Lecture)
Y.J. Kim, Seoul National University College of Medicine, Seoul, Korea
226
13:30 MAJOR NON-CARDIAC SURGERY IN PATIENTS WITH AORTIC STENOSIS - SAME AS 20 YEARS AGO? (Invited Lecture)
S. Pislaru, Mayo Clinic College of Medicine, Rochester, MN, USA
 
227
13:45 SURGICAL TIMING FOR INFECTIVE ENDOCARDITIS (Invited Lecture)
D.H. Kang, University of Ulsan, Asan Medical Center, Seoul, Korea
228
14:00 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 28, 2013
11:15-13:45   HALL B

 

PL10   Plenary Session:
ARRHYTHMIA, ELECTROPHYSIOLOGY AND STROKE PREVENTION

Chairs:
C. Snyder, Cleveland, OH, USA
A. Khoynezhad, Los Angeles, CA, USA

 

11:15 THE WORK UP OF ASYMPTOMATIC WOLFF-PARKINSON-WHITE SYNDROME (Invited Lecture)
C. Snyder, W. Hoyt Jr., J. Steinberg, Rainbow Babies and Children’s Hospital, Cleveland, OH, USA
229
11:30 ATRIAL FIBRILLATION AS A GENETIC DISEASE (Invited Lecture)
M.H. Gollob, University of Ottawa Heart Institute, Ottawa, ON, Canada
230
11:45 IS THERE A PERFECT APPROACH FOR ABLATION PERSISTENT ATRIAL FIBRILLATION? (Invited Lecture)
K. Srivathsan, Mayo Clinic, Arizona, AZ, USA
231
12:00 THORACOSCOPIC BIATRIAL MAZE PROCEDURE – A NOVEL MINIMAL-INVASIVE REMEDY WITH PROMISING MIDTERM RESULTS (Invited Lecture)
A. Khoynezhad, Cedars-Sinai Medical Center, Los Angeles, CA, USA
232
12:15 LEFT ATRIAL APPENDAGE CLOSURE (Invited Lecture)
S. Bertog, L. Vaskelyte, I. Hofmann, S. Lam, S. Gafoor, J. Wiebe, H. Sievert, CVC Frankfurt/Minneapolis VA Medical Center, MN, USA
233
12:30 CRYPTOGENIC STROKE - COULD LONG TERM CARDIAC MONITORING UNCOVER THE CAUSE (Invited Lecture)
J. Rod Gimbel, Knoxville, TN, USA
235
12:45 MY PATIENT CANNOT STAND UP: WHAT TO DO ABOUT ORTHOSTATIC HYPOTENSION (Invited Lecture)
S.R. Raj, Vanderbilt University, Nashville TN, USA
236
13:00 ANTICOAGULATION IN PATIENTS WITH SYSTOLIC HEART FAILURE AND SINUS RHYTHM: WHEN? (Invited Lecture)
E. Yetkin, Middle East Hospital, Mercin, Turkey
234
13:15 LONG TERM EFFICACY OF ATRIAL BASED PACING AND BETA BLOCKER THERAPY TO PREVENT SUDDEN CARDIAC DEATH IN CONGENITAL LONG QT SYNDROME
A. Chatterjee, H. Doppalapudi, Y.R. Lau, T. Yamada, H.T. McElderry,
V.J. Plumb, G.N. Kay, University of Alabama at Birmingham, AL, USA
 
238
13:30 ASSOCIATION OF CORRECTED QT INTERVAL WITH LONG-TERM MORTALITY IN PATIENTS WITH SYNCOPE
J. Garg, P. Harikrishnan, N. Balasubramaniyam, C. Palaniswamy, W.S. Aronow, S. Khera, G. Balasubramanian, C. Nabors, S.J. Peterson, S. Sule
Westchester Medical Center, New York Medical College, Valhalla, NY, USA
 
237
13:45 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 28, 2013
11:15 - 13:45   HALL C
  S28   Session:  
NEW INSIGHTS INTO PATHOGENESIS, PREVENTION AND TREATMENT OF CARDIOMYOPATHIES

Chairs:
B.I. Jugdutt, Edmonton, AB, Canada
A.A. Knowlton, Davis, CA, USA
 
11:15 PREVENTIVE AND/OR THERAPEUTIC EFFECT OF NRF2 ACTIVATORS ON DIABETES- OR ANGIOTENSIN II-INDUCED CARDIOMYOPATHY
L. Cai, University of Louisville, Louisville, KY, USA The Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical College, Wenzhou, China
239
11:30 DOES THE ETIOLOGY OF RECIPIENT CARDIOMYOPATHY OR LEFT VENTRICULAR HYPERTROPHY POST TRANSPLANT PREDICT THE LONG TERM INCIDENCE OF CORONARY ALLOGRAFT VASCULOPATHY?
W.I. Khalife, S. Garikipati, R.P. Vivo, P. Nalabothu, S. Johnson,
K. Kislingbury, R. Sharif, A. Charif University of Texas Medical Branch, Galveston, TX, USA
240
11:45 TAKOTSUBO CARDIOMYOPATHY: ANALYSIS FROM THE NATIONAL INPATIENT SAMPLE 2009-2010
P. Krishnamoorthy, J. Garg, C. Palaniswamy, J.A McClung, H. Ahmad
Englewood Hospital and Medical Center, Englewood, NY, USA
241
12:00 PROGNOSTIC VALUE OF FRAGMENTED QRS COMPLEX ON ECG OF HYPERTROPHIC CARDIOMYOPATHY PATIENTS WITH ICD
B.M. Omery, M. Homsi, A.S. Aasar, M. Das
Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA
242
12:15 LIRAGLUTIDE POSTCONDITIONING IS MORE EFFECTIVE THAN EXENDIN-4 IN LIMITING REPERFUSION INJURY IN BOTH WKY AND SHR-SP RATS WITH LEFT VENTRICULAR HYPERTROPHY
B. Faricelli, M. Salomonsson, A. Consoli, T. Engstroem, M. Treiman
University of Copenhagen, Copenhagen, Denmark G. d’Annunzio University, Chieti, Italy
243
12:30 SENSITIVITY AND SPECIFICITY OF COMMONLY USED EKG CRITERION TO ASSESS LEFT VENTRICULAR HYPERTROPHY IN CENTENARIANS
A. Sharma, S. Chatterjee, V. Shetty, E. Lichstein
Maimonides Medical Center, Brooklyn, NY, USA
244
12:45 A CASE OF FATAL FULMINANT MYOCARDITIS PRESENTING AS AN ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND PERSISTENT VENTRICULAR TACHYARRHYTHMIA ASSOCIATED WITH INFLUENZA A (H1N1) VIRUS IN A PREVIOUSLY HEALTHY PREGNANT WOMAN
Z.J. Tharayil, M.A. Ona, D.R. Bashari, A. Charlot, I. Hoskins, M. Timoney, S. Usmani, R. Royzman
Lutheran HealthCare, Brooklyn, NY, USA
245
13:00 MYOCARDIAL INFARCTION.... OR NOT? THE TIME IS “TICKING”
J. Gilson, M. Krishnamurthy, F. Elmi
Easton Hospital, Academic affiliate to Drexel University, Easton, PA, USA
246
12:15 IS TAKOTSUBO CARDIOMYOPATHY A POTENTIAL SIDE EFFECT OF ANTIDEPRESSANT?
J. Kim, I.C. An, G.S. Abela, H.S. Laird-Fick
Michigan State University, East Lansing, MI, USA and Sparrow Health System, Lansing, MI, USA
247
12:30 TELMISARTAN DELAYED INACTIVATION OF CARDIAC NAV1.5 RESULTING CARDIAC DYSFUNCTION
H.K. Kim, S.R. Lee, I-S. Song, S.H. Jeong, D.Y. Seo, N. Kim, J. Han
Cardiovascular and Metabolic Disease Center, Inje University, Busan, Korea
248
13:45 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 28, 2013
11:15 - 13:00   HALL D
  S29   Session:  
MOLECULAR AND CELLULAR CARDIOLOGY / VASCULAR BIOLOGY, BASIC RESEARCH

Chairs:
P.K. Singal, Winnipeg, MN, Canada
 
11:15 CDK5-MEDIATED HYPERPHOSPHORYLATION CONTRIBUTES TO THE LOSS-OF-SIRT1 FUNCTION DURING THE DEVELOPMENT OF ENDOTHELIAL SENESCENCE
B. Bai, Y. Liang, C. Xu, M.Y.K. Lee, A.M. Xu, D.H. Wu, P.M. Vanhoutte,
Y. Wang
Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong
250
11:30 MOLECULAR MECHANISMS UNDERLYING THE PRO-ATHEROGENIC ACTIONS OF INTERFERON-GAMMA
N. Li, J.E. McLaren, D.R. Michael, T.R. Hughes, D.P. Ramji
School of Biosciences, Cardiff University, Museum Avenue, Cardiff, UK
251
11:45 TMEM16A CALCIUM ACTIVATED CHLORIDE CHANNEL IS INVOLVED IN CEREBROVASCULAR REMODELING
Y.Y. Guan, M. Wang, Z. Zhang, Y.B. Tang, J.G. Zhou
Zhongshan School of Medicine, Sun Yet-Sen University, Guanghzhou, China
253
12:00 EFFECTS OF SODIUM BICARBONATE ON HEMODYNAMIC RECOVERY IN HYPOXIC NEWBORN PIGLETS RESUSCITATED WITH ROOM AIR
J-Q Liu, T-F Lee, D.L. Bigam, P-Y Cheung
University of Alberta, Edmonton, AB, Canada
 
027
12:15 DILATED CARDIOMYOPATHY AND MITOCHONDRIAL DYSFUNCTION IN GAB1-DEFICIENT MICE: A ROLE FOR GAB1 IN ADULT HEART
Z. Jin, J. Zhao, F.Q. Jin, C. Wong, M.A. Mastrangelo, Y. Lu, D.M. Mickelsen, Y. Yang, M. Yin
University of Rochester, New York, NY, USA
 
255
12:30 THE EPA:DHA 6:1-INDUCED ACTIVATION OF ENOS IN THE CORONARY ARTERY INVOLVES A COPPER-DEPENDENT PRO-OXIDANT EVENT
F. Zgheel, M. Alhosin, S. Rashid, C. Auger, V.B. Schini-Kerth
Strasbourg University, Illkirch, France
 
252
12:45 CAVEOLIN-1/ABC-A1 COMPLEX-MEDIATED CHOLESTEROL EFFLUX OF LIPID-LADEN CELLS AND DRUG DEVELOPMENT FROM CHINESE HERBAL MEDICINE
D.F. Liao, S.W. Sun
Hunan University of Chinese Medicine, Changsha, Hunan, China
 
249
13:00 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SUNDAY, JULY 28, 2013
14:00 - 15:45   HALL A
 

PL11   Plenary Session:
STABLE ISCHEMIC HEART DISEASE – THERAPEUTIC OPTIONS

Chairs:
M.E. Farkouh, Toronto, ON, Canada
U. Thadani, Oklahoma City, OK, USA

 
14:00 IMPACT OF LIFE STYLE MODIFICATIONS, ANTIANGINALS, ANTIPLATELETS AND LIPID MODIFYING DRUGS AND OF CORONARY ARTERY REVASCULARIZATION ON MORTALITY AND MORBIDITY IN PATIENTS WITH ISCHEMIC HEART DISEASE: TRUTH AND FALSE NOTIONS (Invited Lecture)
U. Thadani, University of Oklahoma HSC and VA Medical Center, Oklahoma City, OK, USA
293
14:15 INTEGRATIVE THERAPY IN CARDIOVASCULAR DISEASE: SAVIOR OR SHAM? (Invited Lecture)
S. Schaefer, University of California, Davis, CA, USA
294
14:30 MEDICAL RISK FACTOR CONTROL IN LARGE TRIALS OF DIABETIC PATIENTS UNDERGOING CORONARY REVASCULARIZATION
M.E. Farkouh, University of Toronto, Toronto, Ontario, Canada
295
14:45 PTEN AND STATINS INDUCED NEW ONSET DIABETES (Invited Lecture)
Y. Ye, S. Ling, M. Bajaj, Y. Birnbaum
Baylor College of Medicine, Houston, TX, USA
296
15:00 ADVANCES IN THE TREATMENT OF CORONARY ARTERY DISEASE IN THE ELDERLY (Invited Lecture)
I. Mikati, Northwestern Memorial Hospital, Chicago, IL, USA
297
15:15 IS THERE A ROLE FOR CORONARY ARTERY CALCIUM (CAC) TESTING IN SYMPTOMATIC PATIENTS IN THE ERA OF CORONARY CT ANGIOGRAPHY? (Invited Lecture)
K. Nasir, Baptist Health South Florida, Johns Hopkins Ciccarone Center for Preventive Cardiology, Miami, FL, USA
298
15:30 CENTRALIZED, STEPPED, PATIENT PREFERENCE–BASED TREATMENT FOR PATIENTS WITH POST–ACUTE CORONARY SYNDROME DEPRESSION: CODIACS VANGUARD RANDOMIZED CONTROLLED TRIAL
K.W. Davidson, Columbia University Medical Center, New York, NY, USA
299
15:45 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 28, 2013
14:00 - 16:15   HALL B
  PL12   Plenary Session:
MOLECULAR SURVIVAL AND REGENERATION IN CARDIAC DISEASE

Chairs:
D.K Das, Farmington, CT, USA
A.M. Gerdes, Old Westbury, NY, USA
 
14:00

ENHANCING STEM CELL ENGRAFTMENT IN THE HEART USING SINGLE CELL MICROENCAPSULATION (Invited Lecture)
D.L. Kraitchman, Johns Hopkins University, Baltimore, MD, USA

300
14:15 CARDIOPROTECTION BY AUTOPHAGY MEDIATED VIA ENDOPLASMIC RETICULUM STRESS (Invited Lecture)
S. Das, I. Lekli, D.K Das, University of Connecticut School of Medicine, Farmington, CT, USA
301
14:30 CARDIAC TISSUE HYPOTHYROIDISM- A MAJOR PLAYER IN DIABETIC CARDIOMYOPATHY (Invited Lecture)
A.M. Gerdes, N.Y. Weltman, New York Institute of Technology, Old Westbury, NY, USA
302
14:45

DNA TOPOISOMERASE II INHIBITORS INDUCE MACROPHAGE ABCA1 EXPRESSION AND CHOLESTEROL EFFLUX--- AN LXR-DEPENDENT MECHANISM (Invited Lecture)
L. Zhang, M. Jiang, Y. Shui, Y. Chen, Q. Wang, X. Ma, X. Li, M. Liu,
Y. Duan, J. Han, Nankai University, Tianjin, China

304
15:00 FAILURE TO OVEREXPRESS UROCORTIN FOLLOWING CARDIOPLEGIC ARREST MAKES THE HEART OF DIABETIC PATIENTS UNDERGOING ON-PUMP CORONARY ARTERY BYPASS GRAFTING MORE SUSCEPTIBLE TO APOPTOSIS AND CARDIAC DYSFUNCTION (Invited Lecture)
T.M. Scarabelli, St John Hospital & Medical Center/Wayne State University SOM, Detroit, MI, USA
305
15:15 PI3K INHIBITORS AS NOVEL CANCER THERAPIES: IMPLICATIONS FOR CARDIOVASCULAR MEDICINE (Invited Lecture)
B. McLean, P. Zhabyeyev, E. Pituskin, I. Paterson, M.J. Haykowsky,
G.Y. Oudit, University of Alberta, Edmonton, AB, Canada
306
15:30

PROTEIN TRANSDUCTION DOMAINS; TARGETED VS. NON-TARGETED TISSUE DELIVERY (Invited Lecture)
M. Zahid, University of Pittsburgh, Pittsburgh, PA, USA

307
15:45 STEM CELLS INDUCED CARDIAC REGENERATION IN DOXORUBICIN INDUCED CARDIOMYOPATHY (Invited Lecture)
D. Singla, University of Central Florida, Orlando, FL, USA
494
16:00 MIR-24 UP-REGULATION UNDERLIES EXCITATION-CONTRACTION UNCOUPLING IN HEART FAILURE
M. Xu, R.C. Li, H.D. Wu, M. Wang, J. Tao, Y.B. Guo, X.J .Wang,
S.Q. Wang, Peking University, Beijing, China
308
16:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION
SUNDAY, JULY 28, 2013
14:00 - 16:45   HALL C
  S30  Session:
ARRHYTHMIA I: SUDDEN CARDIAC DEATH / ADVANCES IN IMPLANTABLE RHYTHM DEVICE THERAPY

Chairs:
J.R. Gimbel, Knoxville, TN, USA
C.A. Henrikson, Portland, OR, USA

 
14:00 EFFECTS OF RESUSCITATION TIME ON OUTCOMES IN CARDIAC ARREST PATIENTS UNDERGOING THERAPEUTIC HYPOTHERMIA
R.M. Van Hoff, A.M. Robert, J.R. Brown, S.H. Conley, A.T. Kono
Dartmouth Hitchcock Medical Center, NH, USA
309
14:15 HIGHLY LETHAL NKX2.5 MUTATION
J.L. Perera, N.M. Johnson, D.P. Judge, J.E. Crosson
Johns Hopkins University, Baltimore, MD, USA
310
14:30 DOES AZITHROMYCIN INCREASE THE RISK OF CARDIOVASCULAR DEATH? A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
R.F. Njoh, B. Njei, R. Vidhun, St. Mary’s Hospital, Waterbury, CT, USA
311
14:45 CLINICAL PROFILE, MANAGEMENT AND OUTCOME OF PATIENTS WITH OUT-OF-HOSPITAL CARDIAC ARREST (OHCA): INSIGHT FROM A 20-YEAR REGISTRY IN THE STATE OF QATAR
A,A. Patel, A.M. Arabi, H.A. Alzaeem, J.M. Alsuwaidi, H.H. Albinali,
R.S. Singh, Hamad Medical Corporation, Doha, Qatar
 

313
15:00 META-ANALYSIS TO DETERMINE CRITICAL TASER BARB DISTANCE FOR MYOCARDIAL CAPTURE
T.A. Dewland, B.T. Young, P.N. Azadani, G.M. Marcus, A. Si,
A. Soleimanirahbar, B.K. Lee
University of California San Francisco, San Francisco, CA, USA
314
15:15 LEFT VENTRICULAR PACING SHOULB BE AN OPTION IN PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
A. Singh, F. Cutcher, A. Tran, E. Bass
Phoenix Heart, Glendale, AZ, USA
315
15:30 TOPICAL ANTIBIOTIC AND SKIN ANTISEPTIC PROPHYLAXIS AFTER PLACEMENT OF CARDIAC ELECTRONIC IMPLANTABLE DEVICE (CEID): A PROSPECTIVE RANDOMIZED TRIAL
K. Khalighi, T.T. Aung, S. Thapamagar, S.R. Walker
Easton Hospital, Department of Medicine, Drexel University College of Medicine, Easton, PA, USA
316
15:45 IMAGING THE PM/AICD PATIENT; AN MRI NEURO-CARDIAC EFFICACY STUDY
R.W. Biederman
, J.A. Yamrozik, G. Rayarao, D. Thompson, R.B. Williams, M. Sha, M. Doyle
Allegheny General Hospital, The Gerald McGinnis Cardiovascular Institute, Pittsburgh, PA, USA
317
16:00 ROLE OF IMPLANTABLE LOOP RECORDER IN THE MANAGEMENT OF ATRIAL FIBRILLATION
S.B. Thapamagar, E. Rakhshan, S. Sooklal, D.A. Mascarenhas
Easton Hospital, Easton, PA, and Drexel University, Philadelphia, PA, USA
319
16:15 STRATEGY OF CARDIOVERSION AND ANTI-ARRHYTHMIC DRUG THERAPY FOR ATRIAL FLUTTER/FIBRILLATION INDUCED TACHYCARDIA MEDIATED CARDIOMYOPATHY – A SINGLE CENTER EXPERIENCE
S. Vallurupalli, F. Shailesh, S. Kasula, S. Pant, M. Abed, H. Paydak
University of Arkansas for Medical Sciences, Little Rock, Arkansas
320
16:30 MICROBIOLOGICAL DIFFERENCES OF POCKET VS. NON-POCKET CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE INFECTIONS
A. Kaji, D.H. Lee, A. Kohut, S. Kutalek
Drexel University College of Medicine, Philadelphia, PA, USA
321
16:45 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 28, 2013
16:45-19:00   HALL A
  PL13   Plenary Session:
CAN WE BUILD A BETTER MODEL: CVD RISK PREDICTION

Chairs:
M.A. Alpert, Columbia, MO, USA
M.H. Criqui, La Jolla, CA, USA
 
16:45 CORONARY ARTERY CALCIUM DENSITY AND CARDIOVASCULAR DISEASE EVENTS (Invited Lecture)
M.H. Criqui, J.O. Denenberg, J.H. Ix, R.L. McClelland, C.L. Wassel,
D.E. Rifkin, J.J. Carr, M.J. Budoff, M.A. Allison
University of California, San Diego, La Jolla, CA, USA
322
17:00 CAROTID ULTRASOUND EVALUATION OF SUBCLINICAL ATHEROSCLEROSIS IN 2013: PROGRESS AND PITFALLS (Invited Lecture)
J.M. Gardin, Hackensack University Medical Center, Hackensack, NJ, USA
323
17:15 IS DIABETES REALLY A CORONARY HEART DISEASE RISK EQUIVALENT? (Invited Lecture)
N.D. Wong, University of California, Irvine. CA, USA
324
17:30 RISK FACTORS FOR CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE (Invited Lecture)
M.A. Alpert, University of Missouri-Columbia, Columbia, MO, USA
325
17:45 THE HIGH CORONARY DISEASE RISK OF SOUTH ASIAN AMERICANS (Invited Lecture)
A.L. Klatsky, Kaiser Permanente Medical Center, Oakland, CA, USA
326
18:00 MENTAL STRESS INDUCED MYOCARDIAL ISCHEMIA AND ITS TREATMENT (Invited Lecture)
W. Jiang, Duke University Medical Center, Durham, NC, USA
327
18:15 BIDIRECTIONAL RISKS OF CARDIOVASCULAR DISEASE AND COGNITIVE IMPAIRMENT (Invited Lecture)
K. Alagiakrishnan, University of Alberta, Edmonton, Alberta, Canada
328
18:30 ARE GENDER DIFFERENCES IN HEART DISEASE MORE SIGNIFICANT THAN THE SIMILARITIES? (Invited Lecture)
S. Malik, University of California, Irvine, CA, USA
329
18:45 BODY MASS INDEX AS PREDICTOR OF TOTAL AND CARDIAC MORTALITY IN PATIENTS WITH CARDIOVASCULAR DISEASE: A META ANALYSIS OF 49 STUDIES
A. Sharma, E Lichstein, S Chatterjee Maimonides Medical Center, Brooklyn, NY, USA
330
SUNDAY, JULY 28, 2013
16:45 - 18:45   HALL B
 

S31  Session:
THE RELEVANCE OF GENETICS IN PROVIDING UNDERSTANDING AND TREATMENT FOR CARDIOVASCULAR DISEASES THE RELEVANCE OF GENETICS IN PROVIDING UNDERSTANDING AND TREATMENT FOR CARDIOVASCULAR DISEASES


Chairs:
J.N. Bella, Bronx, NY, USA
N. Maulik, Farmington, CT, USA

 
16:45 DIFFERENCES IN PLATELET microRNA PROFILES AFTER ASPIRIN USE ARE ASSOCIATED WITH DIFFERENCES IN WHOLE BLOOD AGGREGATION AND MIGHT IDENTIFY ASPIRIN RESISTANCE
M.G. Kok, C. Mandolini, R. Nieuwland, E.E. Creemers, J.C. Meijers,
S.J. Pinto-Sietsma, Academic Medical Centre, Amsterdam, The Netherlands
331
17:00 ASSOCIATION STUDY OF 10 SELECTED GENE VARIANTS WITH ANGIOGRAPHIC SEVERITY OF CORONARY ARTERY DISEASE
M. Javorsky, V. Vitanov, L. Klimcakova, J. Zidzik, V. Habalova, E. Babjakova, R. Tkacova, J. Salagovic, B. Stancak, I. Tkac
Safarik University, Department of Medicine, Kosice, Slovakia
332
17:15 GENETIC VARIANTS IN FBN-1 AND RISK FOR THORACIC AORTIC DISSECTION AND NON-DISSECTING ANEURYSM: THE YALE STUDY
O. Iakoubova, C. Tong, C. Rowland, M. Luke, V. Garcia, J. Catanese,
J. Catanese, R. Moomiaie, D. Nikas, J. Elefteriades
Celera Incorporated, Alameda, CA, USA
333
17:30 MACROPHAGES TRANSMIT POTENT PROANGIOGENIC EFFECTS OF oxLDL IN VITRO AND IN VIVO INVOLVING HIF-1α ACTIVATION: A NOVEL ASPECT OF ANGIOGENESIS IN ATHEROSCLEROSIS
R. Hutter, W.S. Speidl, C. Valdiviezo, B. Sauter, R. Corti, V. Fuster,
J.J. Badimon, The Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, USA
334
17:45 A GENETIC RISK SCORE FOR ATRIAL FIBRILLATION IS ASSOCIATED WITH CARDIOEMBOLIC STROKE
M.M. Luke, C.H. Tong, J.J. Devlin, C.R. Rowland, C. Mannhalter
Celera, a division of Quest Diagnostics, Alameda, CA, USA
335
18:00 THE ASSOCIATION OF A GENETIC RISK SCORE WITH ATRIAL FIBRILLATION IN TWO HYPOTHETICAL POPULATIONS
M.M. Luke, C.H. Tong, J.J. Devlin, C.R. Rowland
Celera, a division of Quest Diagnostics, Alameda, CA, USA
336
18:15 A NOVEL LAMIN A/C MUTATION IN A DUTCH FAMILY WITH PREMATURE ATHEROSCLEROSIS
A.A. Weterings, I.A. Van Rijsingen, A.S. Plomp, A.H. Zwinderman,
R.H. Lekanne Deprez, M.M. Mannens, M.A. Van Den Bergh Weerman,
A.C. Van Der Wal, S.J. Pinto-Sietsma, Academic Medical Center, Amsterdam, The Netherlands
337
18:30 MIR-301A OVER-EXPRESSION IN BONE-MARROW DERIVED MESENCHYMAL STEM CELLS: DIFFERENTIATION VERSUS PROLIFERATION
A.L. Müller, J. Klassen, S. Neumann, M. Guirgis, M. Ngo, Y. Li, D.H. Freed St. Boniface Research Centre; University of Manitoba, Winnipeg, Canada
338
18:45 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SUNDAY, JULY 28, 2013
16:45 - 19:45   HALL C
  S32  Session:
ARRHYTHMIA II: DIAGNOSIS, DRUG THERAPY, ABLATION

Chairs:
E.S. Gang, Los Angeles, CA, USA
K. Srivathsan, Arizona, AZ, USA
 
16:45 THE EFFECTS OF GENDER, CALCIUM CHANNEL BLOCKERS AND DIGOXIN ON DOFETILIDE THERAPEUTIC EFFICACY AND OUTCOMES: AN ACAP-TIKOSYN REGISTRY ANALYSIS
M. Pierce, C.K. Pamidimukala, J.H. Bastawrose, B.M. Azari, R. Usmani, A.M. Benjo, J. Aziz, W. Pierce, E. Herzog, E.F. Aziz
St. Luke`s and Roosevelt Hospitals, University Hospitals of Columbia University, Columbia University College of Physicians and Surgeons, New York, USA
339
17:00 INTEGRATED CHRONIC CARE MANAGEMENT IN PATIENTS WITH ATRIAL FIBRILLATION: AN EFFECTIVE TREATMENT STRATEGY
J.M.L. Hendriks, R. de Wit, H.J.G.M. Crijns, H.J.M. Vrijhoef, M.H. Prins, R. Pisters, L.A.F.G. Pison, Y. Blaauw, R.G. Tieleman Maastricht University Medical Centre, Maastricht, The Netherlands
340
17:15 INITIAL EXPERIENCE WITH THREE-DIMENSIONAL ANATOMICAL MAPPING DURING CARDIAC PACING LEAD EXTRACTION
B.L. Nguyen, A. Persi, S. Poggi, G. Riitano, A. Piro, C. Gaudio, G. Giunta, A. Ciccaglioni, R.J. Siegel, E.S. Gang, Cardiology Dept, Sapienza University of Rome, Italy David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
066
17:30 AF SURVEILLANCE POST AF ABLATION USING IMPLANTABLE CARDIAC MONITOR
J. Ip, Y. Xie, D. Grimes, K. Jager, J. Boak, D. Gandhi
Sparrow Clinical Research Institute, Lansing, MI, USA
341
17:45 FREQUENCY OF ATRI-VENTRICULAR BLOCK COMPLICATING ST ELEVATION MYOCARDIAL INFARCTION
J. Nealis, A. Mironov, C. Mitre, A. Budzikowski, J. Kassotis
SUNY Downstate Medical Center, Brooklyn, N.Y. USA
342
18:00 ENHANCED ABLATION IN PULMONARY VEIN ANTRUM GUIDED BY MAGNETIC NAVIGATION IMPROVES LONG-TERM OUTCOME OF PAROXYSMAL ATRIAL FIBRILLATION
C.Y. Lu, Y.X. Zhang, R. Zhang, Y Huang, Q .Xu, W.Y, R. Chen, M.H. Liu, S.J. Liu, Institute of Geriatric Cardiology, PLA General Hospital, Beijing, China
343
18:15 RADIOFREQUENCY CATHETER ABLATION VERSUS CRYOABLATION THERAPY FOR TREATMENT OF ATRIAL FLUTTER
S. Aggarwal, R.S. Loomba, T.K. Shah, S. Khosla, R.R. Arora
Chicago Medical School, North Chicago, IL, USA
344
18:30 PHARMACOLOGICAL CONVERSION OF RECENT ONSET ATRIAL FIBRILLATION: A RANDOMIZED STUDY OF PROPAFENONE AND AMIODARONE
H.S. Taha, M.S. Mashaal, R.M. Omar
Faculty of Medicine, Cairo University, Cairo, Egypt
161
18:45 SAFETY AND FEASIBILITY OF ADENOSINE ADMINISTRATION DURING HYBRID ATRIAL FIBRILLATION ABLATION TO TEST DORMANT PULMONARY VEIN CONDUCTION
L.A.F.G. Pison, N. Kumar, Y. Blaauw, K. Vernooy, J. Maassen, H.J. Crijns, M. La Meir
Maastricht University Medical Centre, Maastricht, Netherlands
345
19:00 THROMBOLYSIS OF LEFT ATRIAL APPENDAGE THROMBUS PRIOR TO CARDIOVERSION OR LEFT ATRIAL CIRCUMFERENTIAL ABLATION: A SAFE ALTERNATIVE TO PROLONGED ANTICOAGULATION IN AN URGENT SETTING?
J. Basu, J. Martin, A. Malhotra, K. Rajappan, Y. Bashir
Oxford Heart Centre, John Radcliffe Hospital, Oxford, UK
346
19:15 COMPLICATIONS OF TRANSSEPTAL ACCESS IN PEDIATRIC AND CONGENITAL ELECTROPHYSIOLOGY PROCEDURES
J.C. von Alvensleben, M.D. Dick II, D.J. Bradley, O.H. Alam, M.J. LaPage
University of Michigan, Ann Arbor, MI, USA
347
19:30 RP INTERVAL DURATION IN SURFACE EKG DURING TYPICAL AVNRT IN ELDERLY PATIENTS
J. Misiri, C.B. Kauffman, F. Kusumoto, Mayo Clinic, Rochester, MN, USA
348
 

 

Saturday,
July 27, 2013
Sunday,
July 28, 2013
Monday,
July 29, 2013
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

 

News

Reduced Registration Deadline:
July 15, 2013

Final Program now online. new

The scientific program of the 18th World Congress on Heart Disease has been reviewed by the American Medical Association and approved for a maximum of 25.75 AMA PRA Category 1 Credits™.

Publication of Abstracts: new
Abstracts were published in a special online only supplement issue of the journal CARDIOLOGY.
Click here to view.

 

 

. toronto


Affiliated with

 

    international academy of cardiology

Endorsed by